To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Rosuvastatin to Decrease Risk of Fracture - JUPITER RCT trial

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
March 2025

Rosuvastatin to Decrease Risk of Fracture - JUPITER RCT trial

Vol: 307| Issue: 3| Number:117| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial

JAMA Intern Med. 2015 Feb;175(2):171-7.

Contributing Authors:
JM Peña S Aspberg J MacFadyen RJ Glynn DH Solomon PM Ridker

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Seventeen thousand eight hundred two patients with no history of cardiovascular disease or diabetes but with elevated hs-CRP were randomized to receive rosuvastatin 20 mg daily (n=8,901) or placebo (n=8,901). The primary outcome of interest was incident fracture. Secondary outcomes included subgroup effects by sex and hs-CRP tertiles, as well as site-specific fracture rates. Outcomes were assessed...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue